Sandy Draper
Stock Analyst at Guggenheim
(4.71)
# 348
Out of 4,479 analysts
89
Total ratings
61.54%
Success rate
22.15%
Average return
Main Sectors:
25 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACCD Accolade | Maintains: Buy | $13 → $6 | $3.53 | +69.97% | 5 | Jun 28, 2024 | |
| MEDP Medpace Holdings | Maintains: Buy | $453 → $464 | $404.42 | +14.73% | 10 | Apr 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $207.47 | - | 6 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $201.48 | - | 10 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $19.25 | +76.62% | 6 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $7.82 | +27.88% | 3 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $26.96 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $0.46 | +334.78% | 3 | Jun 16, 2023 | |
| ICLR ICON PLC | Maintains: Buy | $271 → $263 | $318.30 | -17.37% | 7 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $5.88 | +410.20% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $85.76 | +9.61% | 6 | Dec 7, 2022 | |
| TDOC Teladoc Health | Upgrades: Neutral | n/a | $9.40 | - | 5 | Oct 24, 2022 | |
| PRVA Privia Health Group | Maintains: Buy | $36 → $51 | $17.16 | +197.20% | 2 | Aug 12, 2022 | |
| NTRA Natera | Maintains: Buy | n/a | $110.70 | - | 2 | May 25, 2021 | |
| VCYT Veracyte | Maintains: Buy | n/a | $21.26 | - | 2 | May 18, 2021 | |
| EXAS Exact Sciences | Maintains: Buy | n/a | $43.17 | - | 2 | May 12, 2021 | |
| HIMS Hims & Hers Health | Initiates: Hold | n/a | $21.21 | - | 1 | Apr 21, 2021 | |
| AWH Aspira Women's Health | Initiates: Buy | n/a | $1.03 | - | 1 | Mar 29, 2021 | |
| PINC Premier | Maintains: Hold | n/a | $18.50 | - | 3 | Feb 4, 2021 | |
| PSNL Personalis | Initiates: Buy | n/a | $1.20 | - | 1 | Jan 28, 2021 | |
| NEO NeoGenomics | Initiates: Buy | n/a | $13.73 | - | 1 | Jan 28, 2021 | |
| HCAT Health Catalyst | Maintains: Buy | n/a | $6.10 | - | 2 | Apr 22, 2020 | |
| VEEV Veeva Systems | Maintains: Buy | n/a | $182.85 | - | 2 | Mar 26, 2020 | |
| MDRX Veradigm | Downgrades: Hold | n/a | $9.66 | - | 1 | Jan 16, 2018 | |
| INCR InterCure | Upgrades: Buy | n/a | $2.05 | - | 2 | May 31, 2017 |
Accolade
Jun 28, 2024
Maintains: Buy
Price Target: $13 → $6
Current: $3.53
Upside: +69.97%
Medpace Holdings
Apr 24, 2024
Maintains: Buy
Price Target: $453 → $464
Current: $404.42
Upside: +14.73%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $207.47
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $201.48
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $19.25
Upside: +76.62%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $7.82
Upside: +27.88%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $26.96
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $0.46
Upside: +334.78%
ICON PLC
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $318.30
Upside: -17.37%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $5.88
Upside: +410.20%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $85.76
Upside: +9.61%
Teladoc Health
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $9.40
Upside: -
Privia Health Group
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $17.16
Upside: +197.20%
Natera
May 25, 2021
Maintains: Buy
Price Target: n/a
Current: $110.70
Upside: -
Veracyte
May 18, 2021
Maintains: Buy
Price Target: n/a
Current: $21.26
Upside: -
Exact Sciences
May 12, 2021
Maintains: Buy
Price Target: n/a
Current: $43.17
Upside: -
Hims & Hers Health
Apr 21, 2021
Initiates: Hold
Price Target: n/a
Current: $21.21
Upside: -
Aspira Women's Health
Mar 29, 2021
Initiates: Buy
Price Target: n/a
Current: $1.03
Upside: -
Premier
Feb 4, 2021
Maintains: Hold
Price Target: n/a
Current: $18.50
Upside: -
Personalis
Jan 28, 2021
Initiates: Buy
Price Target: n/a
Current: $1.20
Upside: -
NeoGenomics
Jan 28, 2021
Initiates: Buy
Price Target: n/a
Current: $13.73
Upside: -
Health Catalyst
Apr 22, 2020
Maintains: Buy
Price Target: n/a
Current: $6.10
Upside: -
Veeva Systems
Mar 26, 2020
Maintains: Buy
Price Target: n/a
Current: $182.85
Upside: -
Veradigm
Jan 16, 2018
Downgrades: Hold
Price Target: n/a
Current: $9.66
Upside: -
InterCure
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $2.05
Upside: -